Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentre, Non-interventional Post Marketing Study of Safety and Efficacy of NovoEight® (rFVIII) During Long-Term Treatment of Haemophilia A in Japan

NCT02207218 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT02207218
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02207218 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentre, Non-interventional Post Marketing Study of Safety and Efficacy of NovoEight® (rFVIII) During Long-Term Treatment of Haemophilia A in Japan
Lead sponsor
Novo Nordisk A/S
Phase
Observational
Overall status
Completed
Start date
August 4, 2014
Completion date
November 10, 2020
Enrollment
40 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

congenital bleeding disorder, haemophilia a